Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesIs Blind Pancreaticoduodenectomy Justified for Patients with Ampullary Neoplasms
Journal of Gastrointestinal Surgery, 06/29/09
Tien YW et al. - The authors data support a selective use of blind-PD because a significant portion (65%) of benign ampullary neoplasms can be safely and effectively treated by AMP, blind-PD does not treat ampullary cancer at earlier stage, and blind-PD is associated with significantly more complications and significantly longer hospital stay than AMP.
Today in Biliary System/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications
Journal of the American College of Surgeons, 10/30/09
Day case laparoscopic cholecystectomy is feasible
Irish Journal of Medical Science, 11/02/09
Appropriate management of common bile duct stones: A RAND Corporation/UCLA Appropriateness Method statistical analysis
Surgical Endoscopy, 11/19/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09
Image-enhanced endoscopy in practice
Canadian Journal of Gastroenterology, 11/06/09
Sponsor
Article Search
Sponsor